Indoco Remedies Ltd.
Snapshot View

View in App

Prices View details >>

338.45 +4.05 ▲1.2%

07 February 2023, 04:01:00 PM
Volume: 60,705

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.indoco.com
Market Cap 3,099.94 Cr.
Enterprise Value(EV) 3,345.40 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 17.03 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 19.88 Trailing Twelve Months Ending 2022-12
Industry PE 32.80 Trailing Twelve Months Ending 2022-12
Book Value / Share 108.35 Trailing Twelve Months Ending 2022-12
Price to Book Value 3.12 Calculated using Price: 338.45
Dividend Yield 0.67 Period Ending 2022-03
No. of Shares Subscribed 9.22 Cr. 92,150,355 Shares
FaceValue 2
Company Profile
Indoco Remedies is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The Company caters to both domestic and International markets. Indoco has strengthened its wings in the international markets and offers complete solutions, including product development, manufacture and supply of Finished Dosages, APIs and Intermediates to generic companies worldwide. The company has a large basket of products backed by ANDAs / eCTD Dossiers and Drug Master Files (DMFs). Expertise in Research & Development, backward integration in API in select products, own CRO set-up, excellence in Finished Dosages manufacturing and a strong customer base will ensure consistent growth in the Company’s Domestic, as well as International business.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.21%
1 Week
+3.12%
1 Month
-13.91%
3 Month
-6.89%
6 Month
-13.68%
1 Year
-10.32%
2 Year
+7.31%
5 Year
+25.33%
10 Year
+454.38%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 13.32 16.97 14.96 12.55 6.21 -0.43 3.60 12.85 18.50
Return on Capital Employed (%) 16.84 20.63 16.72 11.80 7.62 1.23 5.78 15.67 23.33
Return on Assets (%) 8.17 10.52 9.15 7.22 3.42 -0.24 1.96 7.23 10.63

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 457 519 577 651 675 661 680 769 905 970
Non Curr. Liab. 70 65 66 147 125 116 101 158 157 159
Curr. Liab. 202 262 303 390 417 446 459 407 518 536
Minority Int. 0
Equity & Liab. 729 846 946 1,189 1,218 1,223 1,240 1,334 1,579 1,665
Non Curr. Assets 425 460 481 617 679 684 676 712 712 770
Curr. Assets 305 385 465 572 539 538 563 623 867 895
Misc. Exp. not W/O
Total Assets 729 846 946 1,189 1,218 1,223 1,240 1,334 1,579 1,665

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 733 857 1,008 1,075 1,042 968 1,107 1,242 1,541 1,650
Other Income 4 2 4 6 8 7 5 9 7 2
Total Income 737 859 1,012 1,081 1,050 975 1,111 1,251 1,547 1,652
Total Expenditure -614 -692 -840 -920 -910 -892 -986 -1,023 -1,215 -1,348
PBIDT 122 167 172 160 140 83 126 227 333 304
Interest -19 -11 -12 -6 -24 -21 -26 -22 -17 -19
Depreciation -31 -47 -61 -63 -68 -72 -71 -73 -79 -71
Taxation -14 -27 -17 -14 -7 6 -4 -39 -82 -57
Exceptional Items
PAT 58 83 82 77 41 -3 24 93 155 157
Minority Interest 0
Share Associate 0
Other Related Items 0
Consolidated Net Profit 58 83 82 77 41 -3 24 93 155 157
Adjusted EPS 6 9 9 8 4 0 3 10 17 17

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 69 99 109 112 89 123 132 123 82 174
Cash Fr. Inv. -43 -41 -88 -111 -171 -135 -104 -56 -67 -121
Cash Fr. Finan. -24 -59 -20 -2 132 -39 -16 -64 -30 -44
Net Change 2 -1 1 0 50 -51 12 3 -14 8
Cash & Cash Eqvt 11 10 10 10 60 9 21 24 9 17

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 58.69 58.69 58.54 58.69 58.69 58.69 58.69 58.69 58.69
Public 41.31 41.31 41.46 41.31 41.31 41.31 41.31 41.31 41.31
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 03 Feb 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing schedule for the Investor Call/ Institutional Investors Conference/Meetings.
Thu, 02 Feb 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing schedule for the Investor Call/ Institutional Investors Conference/Meetings.
Tue, 31 Jan 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Conference Call for the quarter and nine months ended 31st December 2022

Technical Scans View Details >>

Tue, 07 Feb 2023
Opening at Low Opening at Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Month High Decrease in 1 Month
MFI Bullish MFI Bullish
Mon, 06 Feb 2023
Higher Trade Quantity Higher Trade Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 1,005.65 -1.7%
Cipla Ltd. 83,244.79 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,441.90 +2.1%
Divi's Laboratories Ltd. 72,982.62 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. 62,084.06 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. 51,953.07 1,533.45 -0.4%
Zydus Lifesciences Ltd. 48,525.07 479.40 +2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 31.56 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 30.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 479.40 +2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 3.67 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 5.87 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 479.40 +2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 479.40 +2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 479.40 +2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 479.40 +2.0%

FAQ's On Indoco Remedies Ltd.

What is Indoco Remedies share price?
Can I buy Indoco Remedies shares now?
What is the Dividend Yield of Indoco Remedies?
What is the Market Cap of Indoco Remedies?
What are the key metrics to analyse Indoco Remedies?
What is the 52 Week High and Low of Indoco Remedies?
What is the trend of Indoco Remedies share price?